These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3945122)
21. Amyloidosis of immunoglobulin origin: useful treatment? Brown MP; Walls RS Med J Aust; 1990 Jan; 152(2):95-7. PubMed ID: 2104951 [TBL] [Abstract][Full Text] [Related]
22. Primary systemic amyloidosis with delayed progression to multiple myeloma. Rajkumar SV; Gertz MA; Kyle RA Cancer; 1998 Apr; 82(8):1501-5. PubMed ID: 9554527 [TBL] [Abstract][Full Text] [Related]
23. Amyloidosis-a deadly disease. Murphy KE Am J Nurs; 1980 Jul; 80(7):1336-8. PubMed ID: 6901584 [No Abstract] [Full Text] [Related]
24. Primary cardiac amyloidosis with 20-year survival. Fealey ME; Edwards WD; Grogan M; Dispenzieri A Cardiovasc Pathol; 2006; 15(6):331-5. PubMed ID: 17113011 [TBL] [Abstract][Full Text] [Related]
25. [Systemic Al-amyloidosis. Clinical course and limits of melphalan therapy]. Hetzel GR; Heering P; Grabensee B Med Klin (Munich); 1999 Oct; 94(10):549-55. PubMed ID: 10554513 [TBL] [Abstract][Full Text] [Related]
26. [Three patients with primary AL amyloidosis treated by high-dose melphalan with autologous peripheral blood stem cell transplantation]. Mukai S; Kanashima H; Ogawa Y; Nakao T; Teshima H; Yamane T Gan To Kagaku Ryoho; 2012 Apr; 39(4):625-7. PubMed ID: 22504689 [TBL] [Abstract][Full Text] [Related]
27. Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosis. Gertz MA; Kyle RA Am J Hematol; 1993 Oct; 44(2):125-8. PubMed ID: 8266917 [TBL] [Abstract][Full Text] [Related]
31. [Current management of amyloidosis]. Hirayama C Nihon Rinsho; 1991 Apr; 49(4):956-60. PubMed ID: 2072560 [No Abstract] [Full Text] [Related]
32. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis. Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045 [TBL] [Abstract][Full Text] [Related]
33. [Primary amyloidosis associated to severe factor X deficiency]. Pérez Martínez J; Llamas F; López Montes A; Massó P; Poblet E; López Rubio E; Gallego E; Gómez Roldán C Nefrologia; 2004; 24(5):493-8. PubMed ID: 15648909 [TBL] [Abstract][Full Text] [Related]
34. [Malabsorption syndrome and intestinal pseudoobstruction in primary vascular and heart amyloidosis]. Schulz HJ; Reitzig P; Lisewski G; Dietze F Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):233-44. PubMed ID: 4792424 [No Abstract] [Full Text] [Related]
35. Successful treatment of primary amyloidosis with dimethylsulfoxide and cytoreductive chemotherapy. Shibuya T; Murakawa M; Tsuda Y; Harada M Intern Med; 1992 Apr; 31(4):544-8. PubMed ID: 1633367 [TBL] [Abstract][Full Text] [Related]
36. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis. Sanchorawala V; Seldin DC Amyloid; 2007 Dec; 14(4):261-9. PubMed ID: 17968685 [TBL] [Abstract][Full Text] [Related]
37. [A case of primary amyloidosis]. Ardashev VN; Potekhin NP; Rukavitsyn OA; Borisov AG; Malysheva SA Klin Med (Mosk); 2006; 84(6):56-9. PubMed ID: 16875072 [TBL] [Abstract][Full Text] [Related]
38. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis. Tazawa K; Katoh N; Shimojima Y; Matsuda M; Ikeda S Amyloid; 2009 Dec; 16(4):243-5. PubMed ID: 19922338 [TBL] [Abstract][Full Text] [Related]